Snowden Capital Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$474K Buy
2,535
+39
+2% +$7.17K 0.01% 864
2026
Q1
$471K Buy
2,496
+135
+6% +$28.4K 0.01% 826
2025
Q4
$469K Buy
2,361
+241
+11% +$48.7K 0.01% 837
2025
Q3
$430K Buy
2,120
+586
+38% +$104K 0.01% 858
2025
Q2
$270K Buy
1,534
+34
+2% +$5.12K 0.01% 1052
2025
Q1
$202K Buy
+1,500
New +$198K 0.01% 1158
2024
Q4
Sell
-1,258
Closed -$209K 1260
2024
Q3
$209K Buy
+1,258
New +$190K 0.01% 1157

Other funds holding THC

Snowden Capital Advisors's THC Position: Q2 2026 in Review

Snowden Capital Advisors increased its Tenet Healthcare (THC) stake by 1.6% in Q2 2026, buying an estimated $7.17K and bringing the position to 2,535 shares worth $474K. The position accounts for 0.01% of the portfolio, ranked #864.

Snowden Capital Advisors first reported a position in THC in Q3 2024 and has held it in 7 quarters since. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Snowden Capital Advisors held 2,535 shares of Tenet Healthcare worth $474K as of Q2 2026.
  • Snowden Capital Advisors bought 39 Tenet Healthcare shares in Q2 2026, an estimated $7.17K.
  • Tenet Healthcare made up 0.01% of Snowden Capital Advisors's portfolio in Q2 2026, its #864 holding.
  • Snowden Capital Advisors first reported a position in Tenet Healthcare in Q3 2024 and has held it in 7 quarters since.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.